Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Using nonprescription, or over-the-counter (OTC), medications to treat common upper respiratory infections could save $4.75 billion a year, according to a new study conducted by researchers from Northwestern University.

26 Oct 2004

Arizona will receive 22,500 additional doses of flu vaccine

Arizona Governor Janet Napolitano announced today that Arizona will receive 22,500 additional doses of flu vaccine as early as Wednesday, and will distribute the vaccine to local health departments in the next week.

25 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford’s Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.

25 Oct 2004

Three additional human cases of West Nile virus in Mississippi

Today the Mississippi Department of Health confirmed three additional human cases of West Nile virus - one in Clay County, one in DeSoto County, and one in Grenada County residents. Health officials also report one additional death that occurred in a previously reported human case from Hinds County.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

BMA report hopes to raise awareness about the threat of biological weapons

A new report released today (25 October 2004) by the BMA paints a bleak picture of the global community's ability to cope with advances in biological and genetic weapons technology.

25 Oct 2004

MedImmune bumps up production of FluMist vaccine

MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed production of 1.1 million doses.

22 Oct 2004

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Molecule that helps DNA replicate may make good target for cancer therapy

In order to divide, cells must first replicate their chromosomes. Cells use an array of proteins to accomplish the job, including a large enzyme complex that synthesizes new strands of DNA.

21 Oct 2004

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

Researchers identify a protein that could banish allergies

The suffering of millions of people with allergies could one day be eased thanks to new research from UK investigators. Findings from the University College London branch of the Ludwig Institute for Cancer Research (LICR), published in the Oct 2004 issue of Nature, detail how inactivating a key signalling molecule called p110delta reduced the effect of allergies on mice.

21 Oct 2004

New antibody to prevent respiratory syncytial virus in premature babies

Virginia Commonwealth University researchers are studying the effectiveness of introducing a new antibody in premature infants to manage the most common form of lower respiratory tract infections in children worldwide.

21 Oct 2004

New law will help stop litigation abuse against vaccines

U.S. Senator Larry Craig announced that legislation will be signed into law in a few days by President Bush which will help avert future flu vaccine shortages.

21 Oct 2004

Women with late effects of polio experience menopause differently than their non-disabled peers

Women with late effects of polio experience menopause differently than their non-disabled peers – physiologically, physically and psychologically – according to a new study funded by Post-Polio Health International.

19 Oct 2004

Antibiotics are still being overused for treating common colds in New Zealand

A medical researcher at The University of Auckland says antibiotics are still being overused for treating common colds in New Zealand, despite researching showing their ineffectiveness.

18 Oct 2004

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant from the National Institutes of Health in the USA to develop a vaccine against Group A streptococcus. This extremely prestigious grant makes QIMR one of the most successful recipients of NIH funding in Australia.

18 Oct 2004

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Nonprescription medications to treat upper respiratory infections could save $4.75 billion a year

Arizona will receive 22,500 additional doses of flu vaccine

Scientists are testing the effectiveness of a new type of flu vaccine

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

Three additional human cases of West Nile virus in Mississippi

Infectious diseases physicians call for financial incentives for industry

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

Who should and who should not get a flu shot?

BMA report hopes to raise awareness about the threat of biological weapons

MedImmune bumps up production of FluMist vaccine

New method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Molecule that helps DNA replicate may make good target for cancer therapy

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Researchers identify a protein that could banish allergies

New antibody to prevent respiratory syncytial virus in premature babies

New law will help stop litigation abuse against vaccines

Women with late effects of polio experience menopause differently than their non-disabled peers

Antibiotics are still being overused for treating common colds in New Zealand

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in